2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC
Announces Second Quarter 2026 Financial Results and Provides Business Update
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Announces Pricing of Public Offering of Common Stock
Investor Presentation
Humacyte, Inc. Increases Authorized Shares to 550 Million
Other Events
Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess®
Q2
Q1
FY 2025
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Notification Filed by a National Security Exchange
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Correspondence
Submission Upload